InvestorsHub Logo
Followers 132
Posts 6427
Boards Moderated 0
Alias Born 05/13/2014

Re: Vanilla Fitbit post# 23238

Monday, 09/28/2020 7:31:08 AM

Monday, September 28, 2020 7:31:08 AM

Post# of 44690
It’s like 50million shares for GEM, who has been investing in Relief for several years. Small potatoes on the OS so I don’t see it as being “railroaded by dilution,” but I understand what you’re thinking here.

Capital from GEM helped RLF do what it needed to do to get up on QB and I just believe that now they have cash in the coffers to roll this thing out with NeuroRX and bring us up to the Nasdaq. I don’t care that the OS went from 2.3billion to 2.8billion. If GEM wants to part with shares at .60 then that’s fine and IMO those will be absorbed quickly. Sensibly I would think GEM would like to see the SP gain traction, get over $1.00 and up-list before letting go of many. They are the largest holder and have been putting in lots of cash. Also the press states that they don’t need anymore cash beyond this to complete trials & scale RLF so I view that as a very good thing. Let’s see them stick to it.

Don’t get me wrong, I am not normally a fan of convertible deals / warrant issuance in general but these Biotechs are kinda in a different realm IMO because they can get bought out SO FAST..... I have gotten impatient before and missed the big ride on these.... I’m strapped in. Lol.

GLTYA $RLFTF